Gergely, B.,
Vereb, M. A.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
Cancers. 17 (5), 1-17, (article identifier: 731), 2025.
Tóth, A.,
Lente, G.,
Csiki, D. M.,
Balogh, E.,
Szöőr, Á.,
Nagy, B. J.,
Jeney, V.:
Activation of PERK/eIF2α/ATF4/CHOP branch of endoplasmic reticulum stress response and cooperation between HIF-1α and ATF4 promotes Daprodustat-induced vascular calcification.
Front. Pharmacol. 15, 1-12, (article identifier: 1399248), 2024.
Ababneh, H. M.,
Tóth, A.,
Lente, G.,
Balogh, E.,
Csiki, D. M.,
Nagy, B. J.,
Szöőr, Á.,
Jeney, V.:
High phosphate and calcium induce osteoblastic phenotype switching and calcification of corneal epithelial cells in a Runx2-dependent and synergistic manner; a possible mechanism of chronic kidney disease-associated corneal calcification.
Biochim. Biophys. Acta. Mol. Basis Dis. 1870 (5), 1-20, (article identifier: 167171), 2024.
Lupsa, N.,
Érsek, B.,
Böröczky, C.,
Kis, D.,
Szarka, E.,
Lumniczky, K.,
Sáfrány, G.,
Zádori, Z. S.,
Szöőr, Á.,
Buzás, E.,
Pos, Z.:
High sensitivity of host Helios+/Neuropilin-1+ Treg to pretransplant conditioning hampers development of OX40 bright/integrin-β7+ regulatory cells in acute gastrointestinal GvHD.
Eur. J. Immunol. [Epub ahea dof print], 2024.
Barden, M.,
Elsenbroich, P. R.,
Haas, V.,
Ertelt, M.,
Pervan, P.,
Velas, L.,
Gergely, B.,
Szöőr, Á.,
Harrer, D. C.,
Bezler, V.,
Holzinger, A.,
Friis, R. U. W.,
Vereb, G.,
Schütz, G.,
Schoeder, C. T.,
Hombach, A. A.,
Abken, H.:
Integrating binding affinity and tonic signaling enables a rational CAR design for augmented T cell function.
J. Immunother. Cancer. 12 (12), 1-14, (article identifier: 010208), 2024.
Nagy, L.,
Mezősi-Csaplár, M.,
Rebenku, I.,
Vereb, G.,
Szöőr, Á.:
Universal CAR T cells targeted to HER2 with a biotin-trastuzumab soluble linker penetrate spheroids and large tumor xenografts that are inherently resistant to trastuzumab mediated ADCC.
Front. Immunol. 15, 1-38, (article identifier: 1365172), 2024.
Barden, M.,
Holzinger, A.,
Velas, L.,
Mezősi-Csaplár, M.,
Szöőr, Á.,
Vereb, G.,
Schütz, G.,
Hombach, A. A.,
Abken, H.:
CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
Front. Immunol. 14, 1-13, (article identifier: 1110482), 2023.
Mezősi-Csaplár, M.,
Szöőr, Á.,
Vereb, G.:
CD28 and 41BB Costimulatory Domains Alone or in Combination Differentially Influence Cell Surface Dynamics and Organization of Chimeric Antigen Receptors and Early Activation of CAR T Cells.
Cancers (Basel). 15 (12), 3081-3097, (article identifier: 3081), 2023.
Cserepes, M.,
Nelhűbel, G. A.,
Meilinger-Dobra, M.,
Herczeg, A.,
Türk, D.,
Hegedűs, Z.,
Svajda, L.,
Rásó, E.,
Ladányi, A.,
Csikó, K. G.,
Kenessey, I.,
Szöőr, Á.,
Vereb, G.,
Remenár, É.,
Tóvári, J.:
EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
Cancers (Basel). 14 (10), 1-15, (article identifier: 2407), 2022.
Mezősi-Csaplár, M.,
Szöllősi, J.,
Gottschalk, S.,
Vereb, G.,
Szöőr, Á.:
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models.
Cancers (Basel). 13 (17), 1-19, 2021.
Q3
Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q2
Agricultural and Biological Sciences (miscellaneous)
2020
20.
Tóth, G.,
Szöllősi, J.,
Abken, H.,
Vereb, G.,
Szöőr, Á.:
A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
Int. J. Mol. Sci. 21 (3), 1-11, 2020.
Volpin, V.,
Michels, T.,
Sorrentino, A.,
Menevse, A. N.,
Knoll, G.,
Ditz, M.,
Milenkovic, V. M.,
Chen, C. Y.,
Rathinasamy, A.,
Griewank, K.,
Boutros, M.,
Haferkamp, S.,
Berneburg, M.,
Wetzel, C. H.,
Seckinger, A.,
Hose, D.,
Goldschmidt, H.,
Ehrenschwender, M.,
Witzens-Harig, M.,
Szöőr, Á.,
Vereb, G.,
Khandelwal, N.,
Beckhove, P.:
CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment.
Cancer Immunol. Res. 8, 1163-1179, 2020.
Szöőr, Á.,
Tóth, G.,
Zsebik, B.,
Szabó, V.,
Eshhar, Z.,
Abken, H.,
Vereb, G.:
Trastuzumab Derived HER2-specific CARs for the Treatment of Trastuzumab-Resistant Breast Cancer: CAR T Cells Penetrate and Eradicate Tumors That Are Not Accessible to Antibodies.
Cancer Lett. 484, 1-8, 2020.
Méhes, E.,
Baráth, M.,
Gulyás, M.,
Bugyik, E.,
Geiszt, M.,
Szöőr, Á.,
Lányi, Á.,
Czirok, A.:
Enhanced endothelial motility and multicellular sprouting is mediated by the scaffold protein TKS4.
Sci. Rep. 9 (1), 1-13, 2019.
Velasquez, M. P.,
Szöőr, Á.,
Vaidya, A.,
Thakkar, A.,
Nguyen, T. L. P.,
Wu, M. F.,
Liu, H.,
Gottschalk, S.:
CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells.
Cancer Immunol. Res. 5 (10), 860-870, 2017.
